Overweight, obesity and risk of all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus: a dose–response meta-analysis of prospective cohort studies

European Journal of Epidemiology

Volumn 30, Issue 1, 2015, Pages 35-45

  Liu, Xue ming ^a   Liu, Yu jian ^a,b   Zhan, Jian ^a   He, Qi qiang ^a  

^a WUHAN UNIVERSITY   (China)

^b FengHe (ShangHai) Information Technology Co Ltd   (China)

Author keywords

BMI; Meta analysis; Mortality; Type 2 diabetes

Indexed keywords

ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; DIABETIC PATIENT; FOLLOW UP; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROSPECTIVE STUDY; RISK FACTOR; SYSTEMATIC REVIEW; CARDIOVASCULAR DISEASE; COMPLICATION; FEMALE; MALE; META ANALYSIS; MORTALITY; RISK; RISK REDUCTION;

BODY MASS INDEX; BODY WEIGHT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; OBESITY; OVERWEIGHT; PROSPECTIVE STUDIES; RISK; RISK REDUCTION BEHAVIOR;

EID: 84925493749     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-014-9973-5     Document Type: Article

References (38)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.
2. Sluik D, Boeing H, Montonen J, et al. Associations between general and abdominal adiposity and mortality in individuals with diabetes mellitus. Am J Epidemiol. 2011;174(1):22–34. doi:10.1093/aje/kwr048.
3. Bantle JP, Wylie-Rosett J, Albright AL, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American diabetes association. Diabetes Care. 2008;31:S61–78.
4. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol. 2006;26(5):968–76.
5. McEwen LN, Karter AJ, Waitzfelder BE, et al. Predictors of mortality over 8 years in type 2 diabetic patients: translating research into action for diabetes (TRIAD). Diabetes Care. 2012;35(6):1301–9. doi:10.2337/dc11-2281.
6. Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23). BMJ (Clin Res ed.). 1998;316(7134):823–8.
7. Jackson CL, Yeh HC, Szklo M, et al. Body mass index and all-cause mortality in US adults with and without diabetes. J Gen Intern Med. 2014;29(1):25–33. doi:10.1007/s11606-013-2553-7.
8. Zoppini G, Verlato G, Leuzinger C, et al. Body mass index and the risk of mortality in type II diabetic patients from Verona. Int J Obes Relat Metab Disord. 2003;27(2):281–5. doi:10.1038/sj.ijo.802199.
9. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.
10. National Heart L, Institute B. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, MD: US Department of Health and Human Services Public Health Service, National Institutes of Health. In. 2000.
11. Panel NOEIE. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res. 1998;6(suppl 2):51S–209S.
12. Winter JE, MacInnis RJ, Wattanapenpaiboon N, et al. BMI and all-cause mortality in older adults: a meta-analysis. Am J Clin Nutr. 2014;99(4):875–90.
13. Czernichow SI, Kenge AP, Stamatakis E, et al. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82864 participants from nine cohort studies. Obes Rev. 2011;12(9):680–7.
14. Wells G, Shea B, O’connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
15. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008;156(1):13–22. doi:10.1016/j.ahj.2008.02.014.
16. Wolf HT, Owe KM, Juhl M, Hegaard HK. Leisure time physical activity and the risk of pre-eclampsia: a systematic review. Matern Child Health J. 2014;18(4):899–910. doi:10.1007/s10995-013-1316-8.
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557.
18. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.
19. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res ed.). 1997;315(7109):629–34.
20. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301–9.
21. Weiss A, Boaz M, Beloosesky Y, Kornowski R, Grossman E. Body mass index and risk of all-cause and cardiovascular mortality in hospitalized elderly patients with diabetes mellitus. Diabet Med. 2009;26(3):253–9. doi:10.1111/j.1464-5491.2009.02672.x.
22. Waring ME, Saczynski JS, McManus D, et al. Weight and mortality following heart failure hospitalization among diabetic patients. Am J Med. 2011;124(9):834–40. doi:10.1016/j.amjmed.2011.04.030.
23. Tseng CH. Obesity paradox: differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus. Atherosclerosis. 2013;226(1):186–92. doi:10.1016/j.atherosclerosis.2012.09.004.
24. Perotto M, Panero F, Gruden G, et al. Obesity is associated with lower mortality risk in elderly diabetic subjects: the Casale Monferrato study. Acta Diabetol. 2013;50(4):563–8. doi:10.1007/s00592-011-0338-1.
25. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA. Mortality in people with type 2 diabetes in the UK. Diabet Med. 2006;23(5):516–21. doi:10.1111/j.1464-5491.2006.01838.x.
26. Eeg-Olofsson K, Cederholm J, Nilsson PM, et al. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia. 2009;52(1):65–73. doi:10.1007/s00125-008-1190-x.
27. Church TS, Cheng YJ, Earnest CP, et al. Exercise capacity and body composition as predictors of mortality among men with diabetes. Diabetes Care. 2004;27(1):83–8.
28. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71–82.
29. Carnethon MR, de Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308(6):581.
30. Doehner W, Erdmann E, Cairns R, et al. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol. 2012;162(1):20–6. doi:10.1016/j.ijcard.2011.09.039.
31. Amadou A, Ferrari P, Muwonge R, et al. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev. 2013;14(8):665–78. doi:10.1111/obr.12028.
32. Discacciati A, Orsini N, Wolk A. Body mass index and incidence of localized and advanced prostate cancer—a dose–response meta-analysis of prospective studies. Ann Oncol. 2012;23(7):1665–71.
33. Wells JC. The evolution of human fatness and susceptibility to obesity: an ethological approach. Biol Rev. 2006;81(2):183–205.
34. McAuley PA, Kokkinos PF, Oliveira RB, Emerson BT, Myers JN. Obesity paradox and cardiorespiratory fitness in 12,417 male veterans aged 40 to 70 years. Mayo Clin Proc. 2010;85(2):115–21. doi:10.4065/mcp.2009.0562.
35. Schmidt DS, Salahudeen AK. Obesity-survival paradox-still a controversy? Semin Dial. 2007;20(6):486–92. doi:10.1111/j.1525-139X.2007.00349.x.
36. Lavie CJ, Milani RV, Ventura HO. Obesity and Cardiovascular DiseaseRisk Factor, Paradox, and Impact of Weight Loss. J Am Coll Cardiol. 2009;53(21):1925–32.
37. Ioannides-Demos LL, Proietto J, Tonkin AM, McNeil JJ. Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf. 2006;29(4):277–302.
38. Stommel M, Schoenborn C. Accuracy and usefulness of BMI measures based on self-reported weight and height: findings from the NHANES & NHIS 2001–2006. BMC Public Health. 2009;9(1):421.